comparemela.com
Home
Live Updates
Confluent Health - Breaking News
Pages:
11
12
13
14
15
16
17
Page 10 - Confluent Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Override Raises $3 5M in Seed Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
United states
Pain program
Veterans affairs
Confluent health
Martin ventures
David shulkin
Jennie shulkin
Take courage
Former VA Secretary Teams up With Daughter to Launch Chronic Pain Care Startup
Override provides chronic pain patients with a care team that includes a pain physician, a physical therapist, a psychologist and a coach. The company has received $3.5 million in seed funding and has acquired Take Courage Coaching.
United states
David shulkin
Jennie shulkin
Sword health
Harvard law school
Veterans affairs
Confluent health
Override thursday
Take courage
Take courage coaching
Martin ventures
Hinge health
Weight loss
Medical devices
Healthcare innovation
Medcity news
StartUPDATES: New Developments from Healthcare Startups
Check out new developments from Equiva Health, BehaVR, Juno Medical, Cabinet Medical and Override.
New york
United states
Akili hinson
Daniel freeman
Russell gong
Aachal patel
Serena williams
Aaron gani
Nir altman
Los angeles
David shulkin
Julian eison
Jennie shulkin
Veterans affairs
Oxford science enterprises
Gilda club minnesota
BehaVR and OxfordVR Combine and Raise $13M Series B Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Aaron gani
Oxford science enterprises
Confluent health
United kingdom based
Optum ventures
Accenture ventures
Chrysalis ventures
BehaVR, Oxford VR merge to seize opportunity for new treatments
Virtual reality startups BehaVR and OxfordVR have merged and raised new funding for their efforts to treat chronic pain and anxiety.
Sumitomo pharma
Oxford science enterprises
Confluent health
Optum ventures
vimarsana © 2020. All Rights Reserved.